SESSION XXXIII SCHEDULE
SESSION XXXIII: RECENT ADVANCES AND UPDATES (7-MINUTE TALKS)
x
6:40 AM - 6:47 AM Vascular Challenges After Blunt Trauma To The Thoracic Aorta: Principles In Management And Optimal Techniques For Repair
  Presenters: Kenneth L. Mattox, M.D.  
6:48 AM - 6:55 AM Contemporary Management Of A-V Malformations With A Multidisciplinary Approach
  Presenters: Byung-Boong Lee, M.D.  
6:56 AM - 7:03 AM Why Renal Arteries Get Covered During EVAR: How To Avoid This Mishap
  Presenters: James May, M.D., M.S., F.R.A.C.S., F.A.C.S.  
7:04 AM - 7:11 AM Update On The CardioMems Implantable Pressure Sensor For EVAR: Advantages And Limitations
  Presenters: Ross Milner, M.D.  
7:12 AM - 7:19 AM Direct Intrasac Pressure Measurements Of Selected Patients After EVAR Suggest Long-Term Intrasac Pressure Telemetry May Not Replace Conventional Surveillance Imaging Techniques
  Presenters: Martin Malina, M.D., Ph.D.  
7:20 AM - 7:27 AM Tissue Engineered Vascular Grafts: Will They Ever Work?
  Presenters: Bo Risberg, M.D., Ph.D.  
7:28 AM - 7:37 AM Panel Discussion
Moderator(s): James F. McKinsey, M.D. / Robert B. Rutherford, M.D.  
7:38 AM - 7:45 AM Treatment Strategies For Type II Endoleaks: How My Thoughts Have Changed
  Presenters: Richard A. Baum, M.D.  
7:46 AM - 7:53 AM What I Have Learned About Type II Endoleaks: How Benign They Are; And How To Detect Them
  Presenters: Kim J. Hodgson, M.D.  
7:54 AM - 8:01 AM The Fate Of Endoleaks Detected By CT But Not Detected By Color Flow Duplex Ultrasonography After EVAR: Can They Be Ignored?
  Presenters: Ali F. AbuRahma, M.D.  
8:02 AM - 8:09 AM Type II Endoleaks Are Not So Benign After All: They Can Produce AAA Rupture Without An Associated Type I Endoleak
  Presenters: David C. Brewster, M.D.  
8:10 AM - 8:17 AM Endovascularly Placed CANCION Device For The Treatment Of Refractory Congestive Heart Failure
  Presenters: Steven F. Bolling, M.D.  
8:18 AM - 8:24 AM Panel Discussion
END OF SESSION XXXIII
 
SESSION XXXIV SCHEDULE
SESSION XXXIV: MORE NEW INFORMATION ON ANEURYSMS AND THORACIC AORTIC DISEASE (7-MINUTE TALKS)
x
8:25 AM - 8:30 AM DEBATE: With Ruptured AAA, Endo Repair Is Best For Most Patients - Against The Motion
  Presenters: William P. Paaske, M.D., DrMedSci, FRCS, FRCS Ed, FACS  
8:31 AM - 8:36 AM DEBATE: With Ruptured AAA, Endo Repair Is Best For Most Patients - Against The Motion
  Presenters: Marc R.H. van Sambeek, M.D., Ph.D.  
8:37 AM - 8:45 AM DEBATE: With Ruptured AAA, Endo Repair Is Best For Most Patients - For The Motion
  Presenters: Christos D. Liapis, M.D.  
8:46 AM - 8:53 AM The Relay Thoracic Endograft: Technique And Early Results With A New Kind Of Stent-Graft Which Facilitates Easy Precise Placement In A Tortuous Proximal Aortic Arch
  Presenters: Vicente Riambau, M.D., Ph.D.  
8:54 AM - 9:01 AM EUROSTAR Real World Experience With Thoracic Endografts: Is It A Cause For Optimism Or A Cause For Concern?
  Presenters: Peter L. Harris, M.D., F.R.C.S.  
9:02 AM - 9:09 AM Two- And Three-Dimensional Criteria For Estimating AAA Rupture Risk
  Presenters: Mark F. Fillinger, M.D.  
9:10 AM - 9:17 AM The Need To Include "Best Medical Care In Trials Evaluating Carotid Angioplasty And Stenting"
  Presenters: Anthony J. Comerota, M.D., F.A.C.S.  
9:18 AM - 9:25 AM The VALOR Trial Of Talent Endografts For A Variety Of Thoracic Aortic Lesions In High Risk Patients: The Real World Experience
  Presenters: Mark A. Farber, M.D.  
9:26 AM - 9:33 AM Debate: IVUS Is The Best Adjunctive Method For Performing Thoracic Endografting: What Are Its Limitations?
  Presenters: Rodney A. White, M.D.  
9:34 AM - 9:41 AM Debate: Transesophageal Echo Is The Best Adjunctive Method For Performing Thoracic Endografting: What Are Its Limitations?
  Presenters: Dietmar H. Koschyk, M.D.  
9:42 AM - 9:49 AM Low Permeability Modifications Of The Gore Excluder And TAG Grafts Affect AAA And TAA Sac Behavior In A Beneficial Way
  Presenters: Thomas C. Naslund, M.D.  
9:50 AM - 10:00 AM Panel Discussion
END OF SESSION XXXIV
 
SESSION XXXV SCHEDULE
SESSION XXXV: NEW DEVELOPMENTS IN THE MANAGEMENT OF CAROTID, VERTEBRAL AND SUPRA-AORTIC TRUNK DISEASE (7-MINUTE TALKS)
x
10:01 AM - 10:08 AM Factors Correlating With Restenosis After CEA: Can They Be Modified And Decrease Restenosis?
  Presenters: Glenn M. LaMuraglia, M.D.  
10:09 AM - 10:16 AM Natural History Of Carotid Artery Occlusion Contralateral To A CEA: Itís More Benign Than We Thought
  Presenters: Ali F. AbuRahma, M.D.  
10:17 AM - 10:24 AM Update On Results Of The CAPTURE Trial: What Does It Mean In The CAS Versus CEA Debate?
  Presenters: Ronald M. Fairman, M.D.  
10:25 AM - 10:32 AM Mini Skin Incision For CEA: A Safe Alternative To The Standard Approach: Indications And Contraindications
  Presenters: Enrico Ascher, M.D.  
10:33 AM - 10:40 AM Vertebral PTA And Stenting With Embolic Protection: How To Do It And Is It Necessary?
  Presenters: Karthikeshwar Kasirajan, M.D.  
10:41 AM - 10:48 AM Is Carotid Plaque Morphology Or Degree Of Stenosis More Important In Determining Prognosis Of An Individual Lesion In Terms Of Natural History; In Terms Of CAS?
  Presenters: Frans L. Moll, M.D., Ph.D.  
10:49 AM - 10:56 AM Intraoperative Imaging After CEA Does Not Improve Outcomes
  Presenters: Caron B. Rockman, M.D.  
10:57 AM - 11:04 AM Tips And Tricks For Managing Carotid Body Tumors
  Presenters: Wesley S. Moore, M.D.  
11:05 AM - 11:13 AM Panel Discussion
END OF SESSION XXXV
 
SESSION XXXVI SCHEDULE
SESSION XXXVI: OTHER NEW DEVELOPMENTS IN STENTING OF THE CAROTID BIFURCATION AND SUPRA-AORTIC TRUNKS (6- AND 7-MINUTE TALKS)
x
11:14 AM - 11:21 AM When Should We Attempt To Open An Occluded Carotid Or Vertebral Artery? How Should It Be Done?
  Presenters: L. Nelson Hopkins, M.D.  
11:22 AM - 11:29 AM Transcervical Approach To CAS: 3-Year Follow-Up Of 100 Patients: Should It Be A Routine Approach?
  Presenters: Enrique Criado, M.D., F.A.C.S.  
11:30 AM - 11:37 AM Why Are Randomized Clinical Data The Only Way To Compare The Outcomes Of CAS With Those Of CEA? Do We Yet Have Any Valid Comparative Outcome Results From Anywhere In The Globe?
  Presenters: Robert W. Hobson II, M.D.  
11:38 AM - 11:44 AM Debate: Carotid Stenting Is Ready For General Acceptance And Usage
  Presenters: Mark H. Wholey, M.D.  
11:45 AM - 11:51 AM Debate: Carotid Stenting Is Not Ready For General Acceptance And Usage
  Presenters: Marc Bosiers, M.D.  
11:52 AM - 11:59 AM What Are The Real World Current Stroke And Death Rates For CEA Based On 2 Statewide Studies? How Do They Impact On The Present Role For CAS?
  Presenters: Bruce A. Perler, M.D., M.B.A.  
12:00 PM - 12:07 PM Ischemic Preconditioning To Facilitate Use Of Balloon Embolic Protection (With The PercuSurge Device) When It Is Poorly Tolerated During CAS: How Can This Work And Should The Principle Be Used More Generally?
  Presenters: Peter L. Faries, M.D.  
12:08 PM - 12:18 PM Panel Discussion
END OF SESSION XXXVI
 
SESSION XXXVII SCHEDULE
SESSION XXXVII: UPDATES, NEW CONCEPTS, ADVANCES AND LATE BREAKING TRIALS (6-MINUTE TALKS)
x
12:19 PM - 12:26 PM Open Minimally Invasive Limb Salvage Procedures: A Less Morbid Approach
  Presenters: Peter F. Lawrence, M.D.  
12:27 PM - 12:33 PM How To Deal Surgically With A Heavily And Circumferentially Calcified (Porcelain) Aorta
  Presenters: Olivier A. GoŽau-BrissonniŤre, M.D., Ph.D.  
12:34 PM - 12:40 PM What Effects Beyond Cholesterol Lowering Do Statin Drugs Have In Vascular Disease Patients?
  Presenters: Ralph G. DePalma, M.D.  
12:41 PM - 12:47 PM Whatís New To Facilitate The Endovascular Treatment Of Traumatic Vascular Lesions?
  Presenters: Jan S. Brunkwall, M.D., Ph.D.  
12:48 PM - 12:54 PM Two-Year Results Of The European Superficial Femoral Artery Registry (ESFAR): Lessons Learned
  Presenters: Gerhard Hoffmann, M.D.  
12:55 PM - 1:01 PM Which Graft Is Best For Femorofemoral Bypass - Dacron Or PTFE? Based On Results Of A Randomized Trial In 198 Patients
  Presenters: Torben V. Schroeder, M.D., D.M.Sc.  
1:02 PM - 1:08 PM Isolated Limb Perfusion With Lytic Drugs Can Improve Limb Salvage After Acute Thromboembolism With Extensive Involvement Of Infrapopliteal Arteries
  Presenters: John F. Eidt, M.D.  
1:09 PM - 1:15 PM Influence Of Real-Time Hemodynamic Monitoring On The Outcome Of EVAR For Ruptured AAAs
  Presenters: J. Adam van der Vliet, M.D.  
1:16 PM - 1:22 PM Vascular Abnormalities In Patients With Neurofibromatosis: What The Vascular Surgeon Needs To Know
  Presenters: Peter Gloviczki, M.D.  
1:23 PM - 1:33 PM Panel Discussion
Moderator(s): Michael B. Silva, Jr., M.D. / Frank J. Veith, M.D.  
1:34 PM - 1:40 PM The Boomerang Device For Closure Of Arterial Punctures: Advantages And Limitations
  Presenters: Ali Amin, M.D., F.A.C.S., F.A.C.C., R.V.T.  
1:41 PM - 1:47 PM Is An Iliac Occlusion A Contraindication To EVAR? Techniques To Solve The Problem
  Presenters: William D. Jordan, Jr., M.D.  
1:48 PM - 1:54 PM New Methods And Adjuncts To Expand The Indications For EVAR
  Presenters: Jacques Bleyn, M.D.  
1:55 PM - 2:01 PM Chronic Spinal Cord Injury Increases Aortic Diameter And AAA Formation: What Is The Mechanism?
  Presenters: Ronald L. Dalman, M.D.  
2:02 PM - 2:08 PM Optimal Management Of Paget-Schroetter Syndrome: Does Lysis And Conservative Treatment Work And When Is Rib Resection And Stenting Indicated?
  Presenters: Matthew J. Eagleton, M.D.  
2:09 PM - 2:15 PM Complications And Outcomes Associated With Use Of Retrievable IVC Filters: Do The Devices Make A Difference Based On The Collected FDA Data?
  Presenters: Palma M. Shaw, M.D.  
2:16 PM - 2:22 PM Spontaneous Dissection Of The Abdominal Aorta: Clinical Presentation And Best Therapeutic Options: Open Surgical Versus Endovascular
  Presenters: Mark A. Farber, M.D.  
2:23 PM - 2:29 PM Late Breaking Development: Aptus AAA Endograft With Proximal Fixation Staples
  Presenters: David H. Deaton, M.D.  
2:30 PM - 2:40 PM Panel Discussion
2:40 PM - 2:45 PM Prize Drawing Raffle - $8.000 In Prizes. You Must Be Present To Win!
2:45 PM - 2:45 PM Symposium Ends.
SAVE-THE-DATE:
Wednesday, November 14 - Sunday, November 18, 2007.
SHERATON NEW YORK HOTEL & TOWERS.
PLEASE COME AGAIN.
END OF SESSION XXXVII